The Larvol Group, LLC

4 articles about The Larvol Group, LLC

• LARVOL Launches the First Cancer-Focused Social Listening Platform for Pharma and Oncology

  4/13/2021

  LARVOL , leading provider of data and intelligence solutions for the pharmaceutical and biotech industry, today announced the launch of VIEW , the first curated social listening and sentiment analysis platform focused on Twitter-verified oncologists

• Larvol Launches AI-Powered Cancer Data Platform During ASCO 2020

  6/1/2020

  The Larvol Group, a Software as a Service (SaaS) company with 125 employees, announced the launch of Veri, their new decision support and competitive intelligence tool during the 2020 ASCO Annual Meeting. The Veri platform offers access to a knowledgebase for predictive biomarkers in oncology and is free for non-commercial use. “Veri is an extremely ambitious project and our focus is to move beyond the capabilities of

• Larvol Launches Omni, Its Next Gen KOL and Pharma Tracking Tool

  3/11/2019

  The Omni platform, available on both desktop and mobile devices, offers users the ability to track developments related to Key Opinion Leaders, including conferences, social media, and clinical trials in real time.

• Larvol Transforms Competitive Intelligence Space With Launch of KOL and Pharma Tracking Mobile App

  2/27/2018

  This new mobile experience offers users the ability to track new developments related to Key Opinion Leaders, pharmaceutical products, and clinical trials in real time on their smartphones.